Skip to main content

Oluwadamilola Motunrayo Fayanju, MD, MA, MPHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Fayanju is an Associate Professor of Surgery and Population Health Sciences in the Duke University School of Medicine, Associate Director for Disparities & Value in Healthcare with Duke Forge (the university’s center for actionable data science: https://forge.duke.edu/oluwadamilola-fayanju-md-ma-mphs), and Director of the Durham VA Breast Clinic.

She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Her research, which is supported by an NIH K08 career development award, has 3 areas of focus: (1) addressing disparities in breast cancer presentation, treatment, outcome, and clinical trial participation; (2) improving prognostication and treatment for biologically aggressive variants of breast cancer that are often more common among racial and ethnic minorities; and (3) creating value in oncologic care, especially through the collection and application of patient-reported outcomes (PROs). Her scholarship has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

She is active in several national organizations, currently serving on the Board of Directors for the Surgical Outcomes Club and on various committees including the Breast, Cancer Care Delivery, and Health Disparities Committees for the Alliance for Clinical Trials in Oncology; the Patient-reported Outcomes, Patient Safety and Quality, and Publications Committees for the American Society of Breast Surgeons (ASBrS); the Nominating and Program Committees for the Association for Academic Surgery (AAS); the Women in Surgery Committee for the Society of Black Academic Surgeons (SBAS); and the Locoregional and Patient-reported Outcomes Committees for the Translational Breast Cancer Research Consortium (TBCRC).

Education and Training

  • Breast Surgical Oncology Fellow, Surgery, University of Texas MD Anderson Cancer Center, 2015 - 2016
  • General Surgery Resident, Surgery, Washington University School of Medicine, 2007 - 2015
  • M.P.H.S., Washington University School of Medicine, 2011
  • M.D., Washington University School of Medicine, 2007
  • M.A., Harvard University , 2001
  • A.B., Harvard University , 2001

Publications

Fayanju, O. M., and A. M. Thompson. “Influence of tumour stage at breast cancer detection on survival in modern times: Population based study in 173-797 patients Saadatmand S, Bretveld R, Siesling S, et al (Erasmus Univ Med Centre - Cancer Inst, Rotterdam, Netherlands; Netherlands Comprehensive Cancer Organization, Utrecht; Et al) BMJ 351:h4901, 2015.” Breast Diseases 27, no. 2 (January 1, 2016): 120–21. https://doi.org/10.1016/j.breastdis.2016.04.021.

Full Text

NWAOGU, I. H. E. O. M. A. Y., O. L. U. W. A. D. A. M. I. L. O. L. A. M. FAYANJU, D. O. N. N. A. B. JEFFE, and J. U. L. I. E. A. MARGENTHALER. “Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen.” Molecular and Clinical Oncology 3, no. 5 (September 2015): 1117–22. https://doi.org/10.3892/mco.2015.579.

Full Text

FAYANJU, O. L. U. W. A. D. A. M. I. L. O. L. A. M., I. H. E. O. M. A. NWAOGU, D. O. N. N. A. B. JEFFE, and J. U. L. I. E. A. MARGENTHALER. “Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator.” Molecular and Clinical Oncology 3, no. 4 (July 2015): 775–80. https://doi.org/10.3892/mco.2015.535.

Full Text

Fayanju, Oluwadamilola Motunaryo, Carolyn R. T. Stoll, Susan Fowler, Graham A. Colditz, and Julie A. Margenthaler. “Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.” Ann Surg 260, no. 6 (December 2014): 1000–1010. https://doi.org/10.1097/SLA.0000000000000769.

Full Text

Fayanju, Oluwadamilola M., Susan Kraenzle, Bettina F. Drake, Masayoshi Oka, and Melody S. Goodman. “Perceived barriers to mammography among underserved women in a Breast Health Center Outreach Program.” Am J Surg 208, no. 3 (September 2014): 425–34. https://doi.org/10.1016/j.amjsurg.2014.03.005.

Full Text

Fayanju, Oluwadamilola M., Donna B. Jeffe, Leisha Elmore, Deborah N. Ksiazek, and Julie A. Margenthaler. “Breast cancer patients' experiences within and outside the safety net.” J Surg Res 190, no. 1 (July 2014): 126–33. https://doi.org/10.1016/j.jss.2014.03.030.

Full Text

Fayanju, Oluwadamilola. “Under your nose.” Bull Am Coll Surg 99, no. 1 Suppl (June 2014): 8.

Scholars@Duke

Fayanju, Oluwadamilola M., Iheoma Nwaogu, Donna B. Jeffe, and Julie A. Margenthaler. “Pathologic Complete Response (pCR) in Breast Cancer Patients After Neoadjuvant Chemotherapy at a Comprehensive Cancer Center: The Natural History of an Elusive Prognosticator.” In Annals of Surgical Oncology, 21:49–49. SPRINGER, 2014.

Scholars@Duke

Nwaogu, Iheoma, Oluwadamilola M. Fayanju, Yan Yan, Donna B. Jeffe, and Julie A. Margenthaler. “Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer: the Impact of Chemotherapeutic Regimen.” In Annals of Surgical Oncology, 21:86–87. SPRINGER, 2014.

Scholars@Duke

Pages